| |
|
|
|
|
|
|
|||
|
Blood, 5 March 2009, Vol. 113, No. 10, pp. 2256-2264. Prepublished online as a Blood First Edition Paper on October 23, 2008; DOI 10.1182/blood-2008-03-148809.
Submitted March 31, 2008
Departments of Medicine and Immunology, Duke University Medical Center, Durham, NC, United States * Corresponding author; email: yang0029{at}mc.duke.edu.
Recent advances have suggested a crucial role of the innate immunity in shaping adaptive immune responses. How activation of innate immunity promotes adaptive T cell responses to pathogens in vivo is not fully understood. It has been thought that TLR-mediated control of adaptive T cell responses is mainly achieved by the engagement of TLRs on APCs to promote their maturation and function. In this study, we showed that direct TLR2-MyD88 signaling in CD8 T cells was also required for their efficient clonal expansion by promoting the survival of activated T cells upon vaccinia viral infection in vivo. Effector CD8 T cells that lacked direct TLR2-MyD88 signaling did not survive the contraction phase to differentiate into long-lived memory cells. Furthermore, we observed that direct TLR2 ligation on CD8 T cells promoted CD8 T cell proliferation and survival in vitro in a manner dependent on PI3K-Akt pathway activation, and that activation of Akt controlled memory cell formation in vivo. These results identify a critical role for intrinsic TLR2-MyD88 signaling and PI3K-Akt pathway activation in CD8 T cell clonal expansion and memory formation in vivo and could lead to the development of new vaccine approaches.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||